Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism Prothrombin replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (18 Feb 2022), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemorrhage | CN | 18 Feb 2022 |